(Q83478451)
Statements
The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus (English)
T Forst
B Uhlig-Laske
A Ritzhaupt
U Graefe-Mody
scientific article published on 01 June 2011
No description defined